The acute perturbation of miR-17-19b levels in aggressive lymphomas allowed us to appreciate the fine equilibrium between miR-17-92 and MYC in tumour cells and the biological consequences of this tight balance on in vivo tumour growth. The gene discussed is MYC; the disease is neoplasm.